Summary from the 152nd Meeting of the American Psychiatric Association

Abstract

The 152nd meeting of the American Psychiatric Association was held between 15th and 20th May 1999 in Washington DC; over 15,000 clinicians and researchers were expected to attend. The majority of the data presented at the meeting focused on new clinical research results for recently marketed products. Results from late stage clinical trials on new chemical entities in development were also presented at the conference.

• antidepressants
• depression
• obsessive compulsive disorder
• panic disorder
• SSRIs
• tianeptine